Study for the low and intermediate risk of Neuroblastoma
- Conditions
- INTERMEDIATE AND LOW RISK NEUROBLASTOMATherapeutic area: Diseases [C] - Cancer [C04]
- Registration Number
- EUCTR2010-021396-81-SE
- Lead Sponsor
- INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE VALENCIA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 685
Inclusion Criteria
BASED ON AGE, STAGE, BIOLOGICAL CHARACTERISTICS AND PRESENCE OF SEVERE SYMPTOMS. AS THERE ARE 3 ARMS OF TREATMENT, THE CRITERIA ARE DIFFERENT IN EACH. SEE PROTOCOL
Are the trial subjects under 18? yes
Number of subjects for this age range: 685
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
BASED ON AGE, STAGE, BIOLOGICAL CHARACTERISTICS AND PRESENCE OF SEVERE SYMPTOMS. AS THERE ARE 3 ARMS OF TREATMENT, THE CRITERIA ARE DIFFERENT IN EACH. SEE PROTOCOL
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method